1993•PubMedRequires access

[Clinical applications expected in the future--osteoporosis].

Takeshi Fujita

Open publisher page 0 citations

Abstract

Severe vitamin deficiency causes osteomalacia, but osteoporosis is also associated with decreased vitamin D activity. Intestinal calcium absorption is decreased and vitamin D metabolites low in osteoporosis and cytokine and growth factor abnormalities in osteoporosis may be ascribed to vitamin D deficiency. In Japan, 1 alpha (OH) vitamin D3 and 1.25(OH)2 vitamin D3 have been used for osteoporosis with beneficial effect and scarcely any side effects for many years. World wide, the effect of vitamin D on osteoporosis is gradually recognized. The higher the dose, longer the duration of administration and older the age of the patients, more positive effects tend to be obtained.

About this research paper

What this paper is about

Severe vitamin deficiency causes osteomalacia, but osteoporosis is also associated with decreased vitamin D activity. Intestinal calcium absorption is decreased and vitamin D metabolites low in osteoporosis and cytokine and growth factor abnormalities in osteoporosis may be ascribed to vitamin D deficiency. In Japan, 1 alpha (OH) vitamin D3 and 1.25(OH)2 vitamin D3 have been used for osteoporosis with beneficial effect and scarcely any side effects for many years. World wide, the effect of vitamin D on osteoporosis is gradually recognized. The higher the dose, longer the duration of administration and older the age of the patients, more positive effects tend to be obtained.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Severe vitamin deficiency causes osteomalacia, but osteoporosis is also associated with decreased vitamin D activity. Intestinal calcium absorption is decreased and vitamin D metabolites low in osteoporosis and cytokine and growth factor abnormalities in osteoporosis may be ascribed to vitamin D deficiency. In Japan, 1 alpha (OH) vitamin D3 and 1.25(OH)2 vitamin D3 have been used for osteoporosis with beneficial effect and scarcely any side effects for many years. World wide, the effect of vitamin D on osteoporosis is gradually recognized. The higher the dose, longer the duration of administration and older the age of the patients, more positive effects tend to be obtained.

Key concepts: Osteoporosis, Osteomalacia, Vitamin D and neurology, Medicine, vitamin D deficiency, Internal medicine, Vitamin, Endocrinology

Related papers

Back to paper searchBrowse research topicsOriginal source
[Clinical applications expected in the future--osteoporosis]. — Research Paper | ScholarLens